🇺🇸 FDA
Pipeline program

Tiotropium 'Respimat' 5 mcg

59452

Approved small_molecule active

Quick answer

Tiotropium 'Respimat' 5 mcg for Chronic Obstructive Airway Disease is a Approved program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Chronic Obstructive Airway Disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials